Work

06 01 Luminal A Base Architecture Invasive Breast Carcinoma NST HR+

Year: 2026

Type: article

Abstract: Luminal ER+ breast cancer represents 65-70% of all breast cancer cases and exhibits unique biological characteristics: hormonal dependence, metabolic flexibility, and remarkable capacity for late recurrence (10-20 yearspost-diagnosis) [1, 2]. Conventional therapeutic approaches targeting estrogen signaling achieve initial responsesbut face 20-30% recurrence rates due to compensatory mechanisms [3].I try to model this cancer subtype as a adaptive system that could predicted compesatory responses by the carcinoma along with initial mapping of the carcinomas basic Architecture.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.18163441

Author: Stefan, Ionut Alexandru

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7119506141

FWCI:

Cites:

Cited by:

Related to: